Conference Proceedings
Home
 > 
Browse by Publisher
 > 
BCC Research LLC
 > 
2018 Biotechnology Research Review

2018 Biotechnology Research Review

Send a Friend    
2018 Biotechnology Research Review
Item #: BIO069G
Our Price:   
$2,500.00
Pricing: 
Product Description
Title:2018 Biotechnology Research Review
Report Code:BIO069G
Pages:97
Format:PDF
Publisher:BCC Research LLC
Published:3/14/2019
Keywords:2018 Biotechnology Research Review; Biotechnology Research Review

Summary

Several significant developments have aided and accelerated development and growth of markets in biotechnology, in the period of review. Notable recent advancements in biotechnology are CRISPR, Spheroids for drug development, Quantitative Cell Based Assay using high content analysis platform and Luciferase based high-throughput screening assay. Such technologies assure the wide adoption of cell line technologies for drug development, simplify the gene editing process making it cost-effective.

Companies operating in cell line market are investing huge amount in setting up manufacturing units with advanced state of art facility and expanded production facilities.

Gene therapy technology has opened new avenues which places emphasis on curing disease that do not have an effective therapeutic availability. Johnson & Johnson, together with the University of Pennsylvania, is developing a third-generation AAV-based gene therapy for Alzheimer’s disease. The goal is to use AAV viral delivery to initiate the expression of therapeutic anti-Alzheimer’s antibodies in the brain. The research represents a novel way to get biologics into the brain to treat Alzheimer’s disease and other brain diseases. This is expected to pave way for further innovations in AAV-based gene therapy.

Related Products
Browse By PublisherShop By Category
Dave A Curran, EzineArticles.com Basic Author